This company listing is no longer active
Health House International Past Earnings Performance
Past criteria checks 0/6
Health House International's earnings have been declining at an average annual rate of -69%, while the Healthcare industry saw earnings growing at 8.6% annually. Revenues have been growing at an average rate of 44% per year.
Key information
-69.0%
Earnings growth rate
-37.1%
EPS growth rate
Healthcare Industry Growth | 2.4% |
Revenue growth rate | 44.0% |
Return on equity | n/a |
Net Margin | -83.6% |
Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Health House International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 22 | 19 | -16 | 11 | 0 |
30 Sep 22 | 17 | -17 | 11 | 0 |
30 Jun 22 | 16 | -17 | 11 | 0 |
31 Mar 22 | 13 | -6 | 8 | 0 |
31 Dec 21 | 11 | -5 | 7 | 0 |
30 Sep 21 | 10 | -5 | 7 | 0 |
30 Jun 21 | 8 | -5 | 7 | 0 |
30 Jun 20 | 6 | -3 | 3 | 0 |
Quality Earnings: HHI is currently unprofitable.
Growing Profit Margin: HHI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if HHI's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare HHI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HHI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-4.8%).
Return on Equity
High ROE: HHI's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.